Omega Flex Q2 net profit falls 35.6% to $2.7 million amid cost pressures
Omega Flex reported Q2 2026 net income of $2.675 million, down 35.6% YoY, and EPS of $0.27, down 34.1%. Quarterly sales fell 5.8% to $24.057 million. Management cited higher raw material costs and strategic marketing spend for new products as primary drivers of the profit decline, noting these factors are temporary.
*this image is generated using AI for illustrative purposes only.
Omega Flex, Inc. (OFLX) reported a significant contraction in profitability for the second quarter of 2026, with net income falling 35.6% year-over-year to $2,675,000. The decline was driven by elevated input costs and strategic spending on new product introductions, offsetting a modest dip in sales volumes amid a suppressed housing market.
For the six months ended June 30, 2026, net sales decreased 3.5% to $47,150,000, compared to $48,855,000 in the same period of 2025. The company attributed the sales decline to lower unit volumes, citing continued suppression in the overall market due to declining housing starts. In the second quarter alone, net sales fell 5.8% to $24,057,000 from $25,525,000 in Q2 2025.
Financial Performance
The pressure on the bottom line was more pronounced than on the topline. Net income for the first half of 2026 dropped 38.5% to $4,752,000 from $7,724,000 in H1 2025. Earnings per share (basic and diluted) fell to $0.47 from $0.77 in the prior year period.
| Metric: | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 | Change |
|---|---|---|---|
| Net Sales: | $47,150,000 | $48,855,000 | -3.5% |
| Net Income: | $4,752,000 | $7,724,000 | -38.5% |
| EPS (Basic/Diluted): | $0.47 | $0.77 | -39.0% |
| Metric: | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Change |
|---|---|---|---|
| Net Sales: | $24,057,000 | $25,525,000 | -5.8% |
| Net Income: | $2,675,000 | $4,156,000 | -35.6% |
| EPS (Basic/Diluted): | $0.27 | $0.41 | -34.1% |
Management indicated that approximately 30% of the six-month net income decrease and 54% of the quarterly decrease were attributable to higher raw material costs, including inbound transportation and tariffs, as well as marketing efforts for the new re-engineered flexible gas piping fitting. These costs are expected to be limited in duration as the company builds inventory levels for the new product.
What the Numbers Show
The divergence between revenue and profit performance highlights significant margin compression. While net sales declined by only 3.5% over the first half of 2026, net income contracted by 38.5%. This disparity indicates that gross margins were severely impacted by rising input costs and increased operating expenses related to product certification and marketing. The fact that nearly half of the quarterly profit decline is tied to specific, time-bound initiatives suggests that once inventory normalization occurs, profitability may recover faster than top-line growth.
Strategic Developments
Despite the near-term headwinds, Omega Flex advanced its product portfolio during the period. On July 1, 2026, the company introduced a re-engineered TracPipe System branded flexible gas piping fitting. Designed for both residential and commercial construction, the fitting aims to ease installation and enhance safety, particularly in larger diameter commercial systems up to two inches.
In the healthcare sector, Omega Flex’s subsidiary, Flex-Trac, Inc., announced that its MediTrac corrugated medical tubing (CMT) received CE mark certification under the European Union Medical Device Regulation (EU MDR 2017/745) in August 2026. Classified as a Class IIa medical device, this certification validates compliance with European safety and quality standards. MediTrac CMT is currently installed in healthcare facilities across 48 U.S. states, Canada, the United Kingdom, and Southeast Asia.
Dean W. Rivest, Chief Executive Officer, noted that the CE mark certification, combined with ISO 13485:2016 quality management system certification, positions MediTrac CMT as a scalable growth platform for international expansion. The company continues to invest in equipment and facilities to expand capacity and support geographic growth.
How long is Omega Flex expecting the margin compression from new product introduction costs to persist before profitability stabilizes?
What specific pricing strategies will Omega Flex employ to offset rising raw material and tariff costs without further suppressing sales volumes in a weak housing market?
To what extent does the CE mark certification for MediTrac CMT accelerate Omega Flex's revenue diversification away from its housing-dependent construction segment?
18
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
